| The CAVA Multicentre Dizziness Trial (NCT05984901) | Norfolk and Norwich University Hospitals NHS Foundation Trust | 2022-04-01 |
| Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets (NCT04806282) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 2021-08-17 |
| Pharmacokinetic Profile of Betahistine With and Without Selegiline in Healthy Volunteers (NCT05938517) | Ludwig-Maximilians - University of Munich | 2021-06-02 |
| Ménière's Disease Registry (NCT04438538) | Norfolk and Norwich University Hospitals NHS Foundation Trust | 2020-06-20 |
| CAVA: Dizziness Trial (NCT04026516) | Norfolk and Norwich University Hospitals NHS Foundation Trust | 2019-07-01 |
| Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease (NCT03587701) | Northwell Health | 2019-01-03 |
| SPI-1005 for the Treatment of Patients With Meniere's Disease (NCT03325790) | Sound Pharmaceuticals, Incorporated | 2017-09-28 |
| A 6-Month Extension Study of OTO-104 in Meniere's Disease (NCT02768662) | Otonomy, Inc. | 2016-08-01 |
| Open Label Study of OTO-104 in Subjects With Meniere's Disease (NCT02740387) | Otonomy, Inc. | 2016-06-01 |
| Study of OTO-104 in Subjects With Unilateral Meniere's Disease (NCT02717442) | Otonomy, Inc. | 2016-03-21 |
| Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease (NCT02530931) | University Hospital, Grenoble | 2016-03-16 |
| A 6-Month Extension Study of OTO-104 in Meniere's Disease (NCT02706730) | Otonomy, Inc. | 2016-02-01 |
| Study to Evaluate SPI-1005 in Adults With Meniere's Disease (NCT02603081) | Sound Pharmaceuticals, Incorporated | 2015-12-01 |
| Study of OTO-104 in Subjects With Unilateral Meniere's Disease (NCT02612337) | Otonomy, Inc. | 2015-10-27 |
| Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach (NCT02309099) | University of North Carolina, Chapel Hill | 2014-11-01 |
| A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom (NCT02265393) | Otonomy, Inc. | 2014-10-01 |
| OTO-104 for the Treatment of Meniere's Disease (NCT01412177) | Otonomy, Inc. | 2013-11-01 |
| Latanoprost for the Treatment of Menière's Disease (NCT01973114) | Synphora AB | 2013-10-01 |
| Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets (NCT02718846) | Alvogen Korea | 2013-02-01 |
| Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent (NCT02080312) | University of California, San Diego | 2012-01-01 |
| Famvir for Treatment of Hearing in Unilateral Meniere's Disease (NCT01526408) | House Research Institute | 2011-12-01 |
| Clinical Trial of Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease (NCT01454726) | Beijing Administration of Traditional Chinese Medicine Bureau | 2011-01-01 |
| OTO-104 for Meniere's Disease (NCT01084525) | Otonomy, Inc. | 2010-03-01 |
| Stress Management Therapy for Meniere's Disease (NCT01099046) | Osaka University | 2009-01-01 |
| Efficacy of Local Overpressure Treatment for Meniere's Disease (NCT00831688) | Klinikum der Universitaet Muenchen, Grosshadern | 2005-08-01 |
| Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy (NCT00160238) | Solvay Pharmaceuticals | 2003-01-01 |
| Sildenafil For Meniere's Disease (NCT00145483) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-06-18 |
| Effects of Endolymphatic Sac Drainage With Steroids for Meniere's Disease (NCT00500474) | Osaka University | 1996-04-01 |